• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Glaxo starts development of new drugs and new test centers in India, South Asia

      Posted AtIndia Daily

      Glaxo plans to open six centres on the Indian subcontinent to test promising products such as Lapatinib for breast cancer and Cervarixits, its potential blockbuster vaccine against cervical cancer.

      GlaxoSmithKline has signed a groundbreaking deal with Oxford University to develop experimental cancer drugs in India, writes Ian Lyall.

      The move underlines India's appeal as a low-cost base for research, though GSK stressed it would not be cutting highly- skilled lab jobs in the UK.

      NHS bureaucracy means not all patient trials can be carried out in British hospitals. India, with its huge population and thousands of doctors and researchers, has proved the ideal test-bed for international drugs firms.

      "The UK remains our key research and development base," said GSK. "This collaboration will spread UK expertise and best practice to India."

      According to health information firm IMS Health, cancer drug sales will rise by up to18pc next year.

      November 18, 2005


      Share this Article!

    Back to top^